Arkolith/Insider Trading/VRCA/Form 4

Hayes Christopher G.

CHIEF LEGAL OFFICERVerrica Pharmaceuticals Inc. (VRCA) · full profile →Form 4 · filed Mar 18, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$3K
Net Open-Market Flow
-$3K
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 17, 2025Sell(S)4K$0.65$3K176K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 14, 2025Grant(A)250K—$0250K

Transaction Codes

S
Open-market sale
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-25-008505) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML